Lv111
99636 积分 2020-10-16 加入
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
2小时前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
3个月前
已完结
糖皮质激素对非小细胞肺癌患者接受免疫检查点抑制剂的疗效影响
4个月前
已完结
Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors
5个月前
已关闭
Anti-drug Antibodies Monitoring in Biologics Use: Clinical Implications
5个月前
已完结
Antidrug Antibodies and Drug Development: Challenges in the Immunotherapy Era
5个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
5个月前
已完结
[Effects of COS on promoting the pathological ovarian aging mice ovarian function by regulating immune function]
3个月前
已采纳
[Therapeutic effect of infliximab on moderate and severe active rheumatoid arthritis]
3个月前
已采纳
[1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane]
3个月前
已采纳
[TET2 gene in hematological diseases]
3个月前
已采纳
[Expression, identification and bioactivity characterization of an anti-CD3/anti-CD20 bispecific single-chain antibody]
3个月前
已采纳
[Prelimary study of TFA in surface water of some cities over China]
3个月前
已采纳
[Effects of free fatty acids on nitric oxide synthase activity and mRNA expression in endothelial cell of SD rat aorta]
3个月前
已采纳
[Serological and Molecular Biological Analysis of Rare Cases of p-Blood Type]
3个月前
已采纳
REE geochemistry of suspended sediments from the rivers around the Yellow Sea and provenance indicators
3个月前
已采纳
Preparation and adsorption mechanism of rare earth-doped adsorbent for arsenic(V) removal from groundwater
3个月前
已采纳
皖公网安备34019202002308
